Last $4.81 USD
Change Today -0.09 / -1.84%
Volume 23.1K
VVUS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 9:33 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter Y. Tam

Former President, VIVUS Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

50$3,774,190
As of Fiscal Year 2013

Background*

Mr. Peter Y. Tam served as the President of VIVUS Inc. from November 3, 2009 to October 12, 2013. Mr. Tam served as the Chief Operating Officer of VIVUS, Inc. since December 2009 and as its Senior Vice President of Product & Corporate Development from August 10, 2004 to January 2009. He served as Vice President of Strategic Planning and Corporate Development for VIVUS Inc. from November 2002 to August 2004. He joined VIVUS Inc. in 1993 as Manager of Clinical Research ...

Read Full Background

Corporate Headquarters*

351 East Evelyn Avenue
Mountain View, California 94041

United States

Phone: 650-934-5200
Fax: --

Board Members Memberships*

2009-2013
Former President

Education*

BS 1986
University of California Berkeley
MBA
Santa Clara University

Other Affiliations*

Annual Compensation*

Salary$491,054
Total Annual Compensation$491,054

Stock Options*

All Other Compensation$2,097,799
Exercised Options33,744
Exercised Options Value$192,119
Exercisable Options1,087,256
Exercisable Options Value$2,153,266
Total Value of Options$2,345,385
Total Number of Options1,121,000

Total Compensation*

Total Annual Cash Compensation$2,588,853
Total Short Term Compensation$491,054
Other Long Term Compensation$2,097,799
Total Calculated Compensation$3,774,190
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VVUS:US $4.81 USD -0.09

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$725.0K
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Zubair Ahmed Managing Director, Executive Director and Member of Whistle Blower Committee
GlaxoSmithKline Consumer Healthcare Limited
97.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIVUS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.